Biotech Equity Research Associate (Rare Disease)

Guggenheim Securities; Boston (MA); On-site; USD 140,000 - 165,000; Full time

Job summary

Guggenheim Securities seeks an Equity Research Associate to cover the Biotechnology sector, with a focus on rare diseases and gene therapies. The role blends life sciences insights with financial modeling and market analysis for institutional clients.

You will support the research team with fundamental analysis, build and update financial models, and prepare comprehensive research reports. The position is based in New York or Boston, with regular cross-office collaboration.

Qualifications

• Exceptional academic pedigree, including a PhD in a life science field.
• Ability to search, understand, and interpret scientific and medical publications.
• Experience with PK/PD modeling and clinical trial data is a plus.

Responsibilities

• Support Senior Analyst with bottom-up biotech equity research and fundamental analysis.
• Build and update integrated financial and valuation models for biotech firms.
• Write research reports and notes on themes, events, and news.
• Conduct primary research using financial data, clinical data, and trends.
• Organize physician calls for investors and investor events.
• Update analyst marketing handouts regularly.
• Interact with institutional sales and investor clients.
• Respond to client and internal inquiries on research findings.

Skills

Equity research

Financial modeling

Fundamental analysis

Analytical communication

Python

R

Education

PhD in Life Sciences

Tools

Python

R

PK/PD modeling

Job description

Guggenheim Securities seeks an Equity Research Associate to cover the Biotechnology sector, with a focus on rare diseases and gene therapies. The role blends life sciences insights with financial modeling and market analysis for institutional clients.

You will support the research team with fundamental analysis, build and update financial models, and prepare comprehensive research reports. The position is based in New York or Boston, with regular cross-office collaboration.